FDA’s drug approval backlog increases by 15% by Q3 2026

Market overview

Regulatory uncertainty under interim leadership will slow down drug approvals, particularly for new treatments in high-priority areas like oncology. The agency’s review timelines will extend.

regulatory prediction market

Implied probability (Yes)

65%

More regulatory markets

• UK government increases teacher pay offer by 2%+ in 2027 — 45% Yes
• FIFA issues formal disciplinary action against Trump by 2026-12-31 — 70% Yes
• UK government to allocate £200M for river clean-up by 2026 — 70% Yes
• FIFA issues formal reprimand against U.S. Soccer for Trump interference — 75% Yes
• Trump administration implements AI guardrails by Q4 2026 — 70% Yes
• Senate blocks OMB grant rule by December 2026 — 72% Yes
• Biden administration approves ICE detention project within 6 months — 40% Yes
• Forge Global secures Anthropic approval within 6 months — 75% Yes

Browse all regulatory markets →